Technology Commercialization through Small Business
Concept to Clinic: Commercializing Innovation Program
NIGMS Technology Development Programs (R21 and R01): The technology development R21 and R01 notice of funding opportunities (NOFOs) support technological innovations to advance biomedical research. Example technologies, which might originate from biomedical, engineering or physical sciences disciplines, include instruments, devices, processes, algorithms, software, chemicals, biomolecules, or cells that have potential value for generating new basic biomedical research. The NOFOs support the earliest stages of technology development, establishing feasibility/proof of concept and prototype validation, and do not support applications that address new biological questions. Investigators are strongly encouraged to contact program staff (NIGMS_TechDev@nigms.nih.gov) prior to and in preparation for submitting an application to these programs.
Proof of Concept and Value Exploratory Research / Technology Feasibility
Right arrow graphic.
Technology Development R21 Innovative Concepts
Awards
Down arrow graphic.
Prototype Validation Iterative Technology R&D / Validation Studies
Technology Development R01 Verification of Utility
Addressing Biological Questions Applied technology R&D and Dissemination
MIRA Testing Biological Questions
Parent R01 Testing Biological Questions
Late-Stage Technology Optimization for Broad Utility and Self-Sustaining Dissemination
Biomedical Technology Optimization & Dissemination RM1
Send your questions about the programs to the NIGMS tech dev contact mailbox.
